Study day | Procedure | What is done? | Routine | Study |
---|---|---|---|---|
Between 6 months and 2 days preop | CI screening Including: | |||
Hearing tests | Air-conducted and bone-conducted threshold, speech test best aided (with hearing aids) and unaided | x | ||
Study audiologist evaluates if audiological inclusion criteria for study are fulfilled Informing the senior physician | x | |||
Medical talk | Results are discussed | x | ||
Possibilities are explained: hearing preservation/conventional electrodes | x | |||
Decision about hearing preservation electrode | x | |||
Identification for the study Passes potential patients to: assistant physician/study nurse/study audiologist | x | |||
Information about the CI technique | x | |||
Introductory meeting and, when indicated, recruitment (hand out Informed Consent Document) | x | |||
Following | In critical cases the patient’s documents are shown to the chief physician | x | ||
Cost assurance must be checked | x | |||
If CI surgery is indicated, the surgery appointment will be made | ||||
Imaging (e.g., DVT) | x | |||
Between screening and 2 days preop | Study approval | |||
Patient agrees to Informed Consent Document | x | |||
Study audiologist will be informed | x | |||
Blood sample | For pregnancy test, if necessary | x | ||
Blood sample | For γ-GT, transaminases, creatinine | x | ||
Blood sample | Vitamin E baseline detection | x | ||
Questionnaire | The patients complete the NCIQ | x | ||
Imaging (e.g., DVT) | x | |||
Pre-decision of electrode length (for study patients FLEX-electrodes are fixed) | x | |||
Between screening and 3 days preop | Operation appointment | |||
The appointment for operation is sent to the patient | x | |||
Approximately 5 days preop | Patient demonstration | |||
All planned surgeries of the coming week are presented | x | |||
Overview of the planned study patients, if necessary participating at the discussion | x | |||
Between 10 and 2 days preop | Randomization | |||
Fill out patient inclusion form in web-randomization tool Inclusion of the patient in the eCRF database | x | |||
Inform the HCTC about patient’s inclusion in the study | x | |||
2 days preop | Treatment start | |||
Treatment | Starting taking IMPs | x | ||
1–2 days preop | Prefinal diagnostics and patient information | |||
Patient reception | x | |||
Hearing tests | Air-conducted and bone-conducted threshold, speech test best aided (with hearing aids, if available) | x | ||
Vestibularis, BERA, PT | x | |||
Information about the surgery | x | |||
Day 0 | Cochlear implant surgery | |||
Between 1 day preop and day 0 | Blood sample | Vitamin E blood level | x | |
Surgery | The patient has a FLEX-electrode implanted | x | ||
1–5 days postop | Hearing tests | |||
Hearing tests | Air-conducted (if possible) and bone-conducted threshold | x | ||
Test tone | Technical check of the implant | x | ||
Patients return packing of IMPs taken | x | |||
Appointment for the first activation | x | |||
Usually 4 weeks postop, depending on wound healing | First Fitting | |||
Hearing tests | Air-conducted (if possible) and bone-conducted threshold | x | ||
Speech tests in quiet and in noise | x | x | ||
Fitting | Technical check of the implant | x | ||
Blood sample | Vitamin E blood level | x | ||
Questionnaire | The patients complete the NCIQ | x | ||
Patients return packing of IMPs taken | x | |||
Appointment for the 3 months post FF follow-up | x | |||
3, 6, 9 and 12 months post-FF (±14 days each) | Follow-up | |||
Patients return packing of IMPs taken | x | |||
Hearing tests | Speech tests in quiet and in noise | x | x | |
Air-conducted and bone-conducted threshold, (aided threshold) | x | |||
Fitting | Technical check of the implant | x | ||
103 days postop | End of IMP intake | x | ||
Only month 6 post FF | Blood sample | Vitamin E blood level | x | |
Only 3 and 12 months post FF | Questionnaire | The patients complete the NCIQ | x |